Company intelligence / Profile preview

Alia Group

Egypt

Ownership: Private
Development stage: Other

Overview

Alia Group specializes in advanced medical devices for chronic wound care, particularly using TetraSilver Tetroxide Technology. The company has global manufacturing and sales rights for this technology and distributes its products worldwide. Its main focus is on innovative solutions for diabetic foot ulcers, burns, bedsores, and other chronic wounds.

Therapeutic areas: EndocrinologyDermatology
Modalities: Medical deviceTopical wound care technology
Industry: Consumable Medical Devices

Partnerships

Exclusive distributor of TetraSilver technology in Egypt and globally except North America since 2019.

Beyond the preview

Go deeper on Alia Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alia Group.

Explore the full profile